Integrating Multidisciplinary Care in Radiation Oncology for Effective Cancer Management

Hannes Zernin^*
*Correspondence: Hannes Zernin, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy, Email:

Keywords

Radiation oncology • Cancer management • Multidisciplinary care

Introduction

This collaborative approach ensures that the treatment plan considers the unique characteristics of the patient's cancer, its stage and the overall health of the individual. The integration of radiation therapy with other modalities like surgery and chemotherapy is particularly crucial for achieving the best possible outcomes. Radiation therapy works by damaging the DNA within cancer cells, preventing them from dividing and growing. This targeted approach distinguishes radiation oncology from other cancer treatments, allowing for localized treatment of tumors. The field has evolved significantly over the years, with advancements in technology enabling more precise and effective delivery of radiation [1].

Radiation therapists operate the radiation therapy machines and ensure patients are correctly positioned for treatment and they calculate radiation doses, calibrate equipment and perform quality assurance checks to maintain treatment precision They play a crucial role in patient education and support. Dosimetrists work closely with radiation oncologists to design radiation treatment plans. Dosimetrists are precision planners who work closely with radiation oncologists and medical physicists to design individualized radiation treatment plans for cancer patients. In this article, we will explore the vital role of dosimetrists and their contributions to the field of radiation oncology. Dosimetry is the science of measuring and calculating the distribution of radiation doses, both within the treatment area and surrounding healthy tissues (critical structures). Dosimetrists are highly skilled experts who specialize in this crucial aspect of radiation therapy. Medical physicists ensure the safe and accurate delivery of radiation therapy. They use computer software to calculate the optimal distribution of radiation to maximize cancer cell destruction while minimizing harm to normal tissues. In the world of radiation oncology, the term "dosimetrist" might not be as widely recognized as that of a radiation oncologist or medical physicist, yet these healthcare professionals play a pivotal role in ensuring the safety and effectiveness of radiation therapy [2].

Description

Central to radiation oncology is a collaborative and multidisciplinary team of healthcare professionals, each playing a critical role in a patient's cancer care journey. These physicians are the leaders of the team and specialize in prescribing and overseeing radiation treatment plans. They work closely with other oncologists and medical specialists to design individualized treatment strategies. Their primary responsibility is to develop radiation treatment plans that deliver the prescribed radiation dose to the tumor while minimizing exposure to adjacent healthy organs and tissues. Dosimetrists collaborate closely with radiation oncologists and medical physicists to develop individualized treatment plans for cancer patients. These plans are tailored to each patient's specific diagnosis, tumor size, location and overall health. Dosimetrists use advanced imaging technologies, such as CT scans or MRIs, to create three-dimensional representations of the patient's anatomy [3].

This plan outlines the dose, duration and technique for delivering radiation to the tumor while minimizing exposure to healthy tissues and once the decision is made to proceed with radiation therapy, a treatment plan is created. During simulation, patients undergo imaging scans, such as CT or MRI, to precisely map the treatment area. Immobilization devices and positioning aids are often used to ensure consistent and accurate treatment delivery. Radiation therapy can be delivered using various techniques, including external beam radiation, brachytherapy (internal radiation) and proton therapy. Each technique has specific indications and advantages. Throughout treatment, patients are monitored for side effects and adjustments to the treatment plan may be made if necessary. After treatment, patients undergo regular follow-up appointments to assess their progress and address any long-term effects [4].

Radiation oncologists collaborate with medical oncologists (chemotherapy specialists) and surgeons to determine the most appropriate treatment approach. Radiation nurses provide care and support to patients undergoing radiation therapy. They monitor patients for side effects, offer guidance and coordinate care with the rest of the healthcare team. This collaboration ensures a comprehensive strategy tailored to each patient's needs. The journey begins with a consultation where the radiation oncologist evaluates the patient's medical history, conducts a physical examination and reviews diagnostic imaging and pathology reports. Collaboration among specialists ensures that treatment plans are tailored to each patient's unique cancer type, stage and overall health. Combining radiation therapy with other treatment modalities like surgery and chemotherapy often leads to better outcomes, particularly in complex or advanced cases. Precise treatment planning and delivery help minimize damage to healthy tissues, reducing the risk of side effects. Patients receive comprehensive care and support, addressing not only their medical needs but also their emotional and psychological well-being. Multidisciplinary teams often engage in clinical trials and research, fostering innovation and advancing the field of cancer treatment [5,6].

Conclusion

In conclusion, radiation oncology exemplifies the power of a multidisciplinary approach to cancer care. By combining the expertise of radiation oncologists, medical physicists, therapists and other specialists, patients receive personalized and comprehensive care that maximizes treatment efficacy while minimizing side effects. This collaborative model continues to drive advancements in cancer treatment, offering hope and improved outcomes to individuals facing a cancer diagnosis.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

1. Xu, Yanyan, Jingyuan Xiong, Xiyang Sun and Huile Gao. "Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy."Acta Pharm Sin B (2022).

   Google Scholar, Crossref, Indexed at

2. Lachowicz, Malwina, Andrzej Stańczak and Michał Kołodziejczyk. "Characteristic of cyclodextrins: Their role and use in the pharmaceutical technology."Curr Drug Targets 21 (2020): 1495-1510.

   Google Scholar, Crossref, Indexed at

3. Knudson Jr, Alfred G. "Mutation and cancer: Statistical study of retinoblastoma." Proc Natl Acad Sci68 (1971): 820-823.

   Google Scholar, Crossref, Indexed at

4. Veerasamy, Tarmarajen, Samson Eugin Simon and Kuan Onn Tan. "Emerging strategies for sensitization of therapy resistant tumors toward cancer therapeutics by targeting the bcl-2 family, tgf-β, wnt/β-catenin, rassf and mirna regulated signaling pathways."Int J Biochem Cell Biol 137 (2021): 106016.

   Google Scholar, Crossref, Indexed at

5. Sambi, Manpreet, Leila Bagheri and Myron R. Szewczuk. "Current challenges in cancer immunotherapy: Multimodal approaches to improve efficacy and patient response rates."J Oncol 2019 (2019).

   Google Scholar, Crossref, Indexed at

6. Woo, Seng-Ryong, Leticia Corrales and Thomas F. Gajewski. "Innate immune recognition of cancer."Annu Rev Immunol 33 (2015): 445-474.

   Google Scholar, Crossref, Indexed at